The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?

Source: PubMed Diabetologia

Sep, 2007;50 (9): 1791-1794.

P A Halban

Author Information

P A Halban: Department of Genetic Medicine and Development, University Medical Centre, 1 rue Michel-Servet, 1211, Geneva 4, Switzerland. philippe.halban@medecine.unige.ch.

PMID: 17611733 DOI: 10.1007/s00125-007-0740-y

No abstract text available.

Diabetes Mellitus

Drug Industry

Europe

Humans

Research

Societies, Medical

Journal Article

OpenLB
Open Library of Bioscience